Dernières nouvelles pour ArriVent BioPharma (NASDAQ:AVBP) Stock

ARRIVENT BIOPHARMA INC

ArriVent BioPharma

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

ArriVent BioPharma Inc

Needham analyst Scott Berg reiterates Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Buy and maintains $50 price target.

News

Price Target

Reiteration

Analyst Ratings

BRZE

Needham Reiterates Buy on Braze, Maintains $50 Price Target

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine –
– VERITAC-2 data support vepdegestrant as a potential treatment option in patients with ESR1m ER+/HER2- advanced or metastatic breast cancer –
NEW HAVEN, Conn., June 06, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with its partner Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), for vepdegestrant for the treatment of patients with ER-positive (ER+)/human epidermal growth factor receptor 2 (HER2)-negative (ER+/HER2-) ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. This submission is based on results from VERITAC-2 (NCT05654623), a global, randomized Phase 3 trial evaluating vepdegestrant versus fulvestrant.

ARVN

Arvinas Submits NDA To FDA With Partner Pfizer For Vepdegestrant For Treatment Of Patients With ER+/HER2- ESR1-Mutated Advanced Or Metastatic Breast Cancer Previously Treated With Endocrine-Based Therapy

Needham analyst Scott Berg reiterates ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) with a Buy and maintains $140 price target.

TTAN

Needham Reiterates Buy on ServiceTitan, Maintains $140 Price Target

G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.12 by 58.33 percent. This is a 58.33 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $583.61 million which beat the analyst consensus estimate of $580.37 million by 0.56 percent. This is a 4.29 percent decrease over sales of $609.75 million the same period last year.

Earnings

Earnings Beats

GIII

G-III Apparel Group Q1 Adj. EPS $0.19 Beats $0.12 Estimate, Sales $583.61M Beat $580.37M Estimate

U.S. Health Secretary Robert F. Kennedy Jr. has championed &#8220;medical freedom&#8221; while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy.
What Happened: Kennedy announced last week that the Centers for Disease Control and Prevention would remove COVID-19 vaccines from <a href="https://www.benzinga.com/news/25/05/45661031/robert-f-kennedy-jr-says-cdc-drops-covid-vaccine-for-healthy-pregnant-women-children">recommended </a>immunization schedules for healthy children and pregnant women.
The decision bypassed traditional advisory committee processes and shifted coverage from routine recommendations to shared clinical decision-making between doctors and patients.
&#8220;Regarding the vaccines, HHS is restoring the doctor-patient relationship,&#8221; HHS spokesperson Andrew Nixon said in a <a href="https://abcnews.go.com/Health/rfk-jr-promoted-freedom-choice-limiting-vaccines-food/story?id=122526364">statement</a> to ABC News. &#8220;We are encouraging those groups to consult with their health care provider to help them make an informed decision.&#8221;
Kennedy has also pushed to ban Supplemental Nutrition Assistance Program recipients from purchasing candy and soda with food stamps. Ten state governors have submitted waivers to the Agriculture Department requesting permission for such restrictions, according to Kennedy&#8217;s statements at a Make America Healthy Again event in May.
The Food and Drug Administration began <a href="https://www.benzinga.com/government/regulations/25/05/45399804/robert-kennedy-jr-cheers-fda-plan-to-ban-fluoride-supplements-for-children-calls-move-long-overdue">removing fluoride supplements for children </a>from the market, earning Kennedy&#8217;s praise as &#8220;long overdue.&#8221; The agency cited a lack of FDA approval and evidence that these products alter gut microbiomes.
Kennedy&#8217;s broader MAHA initiative has influenced restaurant chains to eliminate seed oils. Biglari Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BH#NYSE">BH</a>) subsidiary Steak &#8216;n Shake switched to beef tallow for French fries, while Sweetgreen Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>), Bloomin&#8217; Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>), and Restaurant Brands International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) have initiated similar transitions.
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/45809455/tesla-stock-climbed-nearly-5-in-friday-pre-market-whats-going-on">Tesla Stock Climbed Nearly 5% In Friday Pre-Market: What&#8217;s Going On?</a>
Why It Matters: Critics argue Kennedy&#8217;s policies contradict his &#8220;medical freedom&#8221; messaging by limiting choices. Removing COVID vaccines from CDC schedules restricts access while claiming to promote freedom.
&#8220;If you restrict access, you necessarily restrict choice,&#8221; Dr. Matthew Ferrari of Pennsylvania State University told ABC News. Public health experts warn Kennedy&#8217;s approach individualizes community health decisions. &#8220;We&#8217;re losing a lot of that underpinning, which has led to a lot of the gains in public health,&#8221; Dr. Craig Spencer of Brown University told ABC News.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45809443/larry-summers-identifies-3-key-reasons-for-rising-us-debt-but-doesnt-think-trumps-big-beautiful-bill-is-the-medicine-the-country-needs">Larry Summers Identifies 3 Key Reasons For Rising US Debt, But Doesn&#8217;t Think Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Is The Medicine The Country Needs</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Health Care

BLMN

MRNA

NVAX

RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts

Scammers are hijacking tariff headlines to trick online shoppers into paying for packages that never arrive, the Better Business Bureau warned this week.
What Happened: BBB spokesperson Melanie McGovern urged consumers to vet unfamiliar retailers, scrutinize delivery windows and read return policies before clicking "buy." In a statement <a href="https://www.usatoday.com/story/money/2025/06/05/package-delays-tariffs-scam/84047764007/">shared</a> with USA Today, McGovern said, &#8220;Scammers rely on consumer confusion, especially when it comes to topics in the news, so doing a little bit extra to make sure the website is legitimate, and that all costs are upfront, can save headaches down the road.&#8221;
Victims typically click a sponsored ad, buy from a slick-looking site and then receive only canned emails urging patience, the BBB says. Weeks later, the seller claims the package is stuck in customs because of new tariffs or demands extra cash to "release" it. Some fraudsters even send tracking numbers that show delivery to the wrong state. A Wisconsin shopper told BBB Scam Tracker she got silence after asking for a refund on shoes delayed "due to tariffs."
U.S. customers rarely owe tariffs after checkout, so any post-purchase demand for customs fees is a red flag, the bureau added. The U.S. Postal Inspection Service urges shoppers to ignore texts that claim package delays and request link clicks.
See also: <a href="https://www.benzinga.com/markets/tech/25/06/45809827/sam-altman-says-ai-can-replace-interns-but-gen-z-is-already-treating-it-like-a-work-buddy">Sam Altman Says AI Can Replace Interns, But Gen Z Is Already Treating It Like A Work Buddy</a>
Why It Matters: To stay safe, experts recommend researching sellers beyond sponsored ads, reading independent reviews and looking for misspellings or odd URLs. Use a credit card, never a debit card or payment app and walk away if asked to pay more after checkout.
The BBB also urges victims to file disputes with their card issuer and report cases to its Scam Tracker, which logged dozens of complaints describing the same "customs hold" ploy. Similar tactics appear in broader package-redirection fraud that manipulates tracking data to block refunds.
Fortalice Solutions CEO Theresa Payton recently called tariff confusion "<a href="https://www.benzinga.com/personal-finance/25/05/45673001/tariff-confusion-creates-the-perfect-storm-for-cybercriminals-consumer-scams-on-the-rise">the perfect storm</a>" for cybercriminals. Similarly, James Lee, the president of the Identity Theft Resource Center, reiterated that it isn&#8217;t unusual for scammers to use a government action as the basis of a scam.
Image via Shutterstock
Read next: <a href="https://www.benzinga.com/markets/tech/25/06/45808672/nvidia-denies-report-of-re-entering-chinese-market-with-custom-ai-chip-despite-us-restrictions-we-are-still-evaluating">Nvidia Denies Report Of Re-Entering Chinese Market With Custom AI Chip, Despite US Restrictions: &#8216;We Are Still Evaluating&#8230;&#8217;</a>

Tech

Scammers Exploit Tariff Confusion To Dupe Online Shoppers Into Paying For Packages That Never Arrive, BBB Warns — Here's How To Spot The Red Flags

Needham analyst Scott Berg reiterates Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) from Hold to Hold.

DOCU

Needham Reiterates Hold on Docusignto Hold

KLAC reverses early weakness at the time of Alert from TradePulse
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/05203640/Screenshot-2025-06-05-at-4.36.07%E2%80%AFPM-1004x1024.png" alt="" class="wp-image-13976" /></figure>
KLA Corp. (KLAC) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:20 AM on June 5th, a significant trading signal occurred for KLA Corp. (KLAC) as it demonstrated a Power Inflow at a price of $780.05. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in KLA's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in KLA's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for KLAC, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts. 
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved
After Market Close, UPDATE: The price at the time of the Power Inflow was $780.05. The returns on the High price ($796.33) and Close price ($791.89) after the Power Inflow are respectively 2.1% and 1.5%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Past results are not Indicative of future results

Equities

Technicals

Opinion

Signals

Trading Ideas

KLA Shares Rise 2.1% After Key Trading Signal

ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) affirms FY2025 Adj EPS guidance from $3.65-$3.80 to $3.65-$3.80 vs $3.77 analyst estimate..

Guidance

ABM Indus Affirms FY2025 Adj EPS Guidance of $3.65-$3.80 vs $3.77 Est

ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) reported quarterly earnings of $0.86 per share which met the analyst consensus estimate. This is a 1.15 percent decrease over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $2.11 billion which beat the analyst consensus estimate of $2.06 billion by 2.47 percent. This is a 4.64 percent increase over sales of $2.02 billion the same period last year.

ABM Indus Q2 Adj. EPS $0.86, Inline, Sales $2.11B Beat $2.06B Estimate

Mosaic Company Revises Outlook: Sees Q2 Sales At 1.5–1.6M Tonnes Vs Prior 1.7M–1.9M; FY Output Trimmed To 7.0M–7.3M Tonnes Vs Prior 7.2M-7.6M Tonnes

Sen. Elizabeth Warren (D-Mass.) has raised alarm over the growing strain on older Americans trying to access their Social Security benefits. Her remarks come amid a wave of <a href="https://www.benzinga.com/personal-finance/25/04/44901238/even-missing-one-monthly-benefit-would-put-me-on-step-to-homelessness-americans-react-to-social-securitys-new-anti-fraud-rules">policy changes</a> and office downsizing at the Social Security Administration (SSA), driven by the Department of Government Efficiency (DOGE) under Elon Musk.
A new report paints a stark picture: millions of seniors are now forced into long, unnecessary travel just to perform basic account updates.
What Happened: Warren reposted a Newsweek <a href="https://www.newsweek.com/doge-social-security-seniors-benefits-elon-2078102">article</a> citing a report highlighting the impact of DOGE-led changes, pointing out that 13.5 million older adults now have to drive more than an hour round trip just to update their banking details.
In another message, she added, "Americans will also take 2 million additional trips to Social Security offices each year. Unnecessary travel burdens make it harder for seniors to collect their checks. Some never will. That's the point."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Americans will also take 2 million additional trips to Social Security offices each year. Unnecessary travel burdens make it harder for seniors to collect their checks. Some never will. That's the point.<a href="https://t.co/3Cy1Ue5TVc">https://t.co/3Cy1Ue5TVc</a>
&mdash; Elizabeth Warren (@ewarren) <a href="https://twitter.com/ewarren/status/1930735622638932133?ref_src=twsrc%5Etfw">June 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The study, released by the Center on Budget and Policy Priorities (CBPP), estimates that new SSA rules and field office reductions are generating close to 2 million additional in-person visits each year.
Many of these trips stem from recent changes requiring beneficiaries to verify identities in person or through a complicated digital process just to make payment-related changes. Phone-based transactions, once a standard option, are <a href="https://www.benzinga.com/news/25/04/44706575/millions-of-seniors-could-be-shut-out-of-social-security-services-as-phone-applications-get-axed-study">now largely unavailable for this purpose.</a>
Devin O'Connor, a senior fellow at CBPP and co-author of the report, noted that the numbers only reflect direct travel time and don't capture the added burden of long waits and limited appointment availability.
"It doesn&#8217;t take into account how long you might spend waiting in a field office or how hard it is to get an appointment to go to a field office in the first place," he said.
See Also: <a href="https://www.benzinga.com/news/politics/25/06/45785851/elizabeth-warren-says-trumps-one-big-beautiful-bill-will-rip-away-health-coverage-from-16-million-a">Elizabeth Warren Says Trump&#8217;s &#8216;One Big Beautiful Bill&#8217; Will &#8216;Rip Away&#8217; Health Coverage From 16 million Americans — Just So Jeff Bezos Can Buy A Third Yacht</a>
Why it Matters: Social Security serves nearly 69 million Americans each month. As the system scales back in-person staffing and narrows remote access, older adults, particularly those in rural areas or with mobility limitations, are disproportionately affected.
In 31 states, more than a quarter of seniors live over an hour away from the nearest SSA location. In some states, including Arkansas and Wyoming, that figure surpasses 40%.
Now-deleted SSA data showed nearly 2,000 employees accepted buyouts earlier this year, straining already thin field office staffing. Former Commissioner Martin O'Malley has warned that the <a href="https://www.benzinga.com/government/25/04/44941777/social-security-payments-could-face-interruptions-in-may-warns-former-commissioner-martin-omalley-never-hoped-i-was-wrong-so-much-in-my-life">system is nearing a breaking point</a>. "Ultimately, you&#8217;re going to see the system collapse and an interruption of benefits," he said in April. "I believe you will see that within the next 30 to 90 days."
The SSA continues to move ahead with planned office closures and <a href="https://www.benzinga.com/news/25/04/44707473/aprils-social-security-changes-how-new-rules-could-affect-your-check">service changes</a>, despite pushback from unions, policymakers, and advocacy groups, while many Americans rush to <a href="https://www.benzinga.com/personal-finance/25/04/45034325/americans-rush-to-claim-social-security-early-amid-growing-fears-of-cuts-and-agency-instability-under-trump-administration">claim benefits early out of fear</a>.
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45785672/trump-is-pleased-because-he-finally-agrees-with-elizabeth-warren-on-something-scrap-the-debt-limit-to-prevent-an-economic-catastrophe">Trump Is Pleased Because He Finally Agrees With Elizabeth Warren On Something: Scrap The Debt Limit To Prevent An &#8216;Economic Catastrophe&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Elizabeth Warren Slams Trump And Musk-Led Policies Forcing 13.5 Million Seniors To Take 2 Million Extra Trips To Access Social Security Services: 'Some Never Will' Collect Their Checks

Needham analyst Mike Matson reiterates Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) from Hold to Hold.

Needham Reiterates Hold on Medtronicto Hold

Concerns are rising among economists over the accuracy of U.S. inflation figures, as federal <a href="https://www.benzinga.com/personal-finance/25/04/44843975/they-dont-give-a-damn-about-you-bernie-sanders-says-if-musk-is-firing-federal-workers-with-a-chainsaw-what-happens-when-ai-comes-for-your-job">staffing limitations</a> begin to disrupt the monthly monitoring of consumer prices. With gaps emerging in data coverage, experts warn that cost-of-living estimates could become increasingly unstable.
What Happened: The Labor Department has acknowledged that its team responsible for tracking monthly changes in consumer prices has shrunk, resulting in the suspension of in-person pricing surveys in several cities, including Buffalo, Provo, and Lincoln, according to a report <a href="https://www.npr.org/2025/06/05/nx-s1-5424367/inflation-data-cpi-government-job-shortages">by</a> NPR. 
This slowdown in field work comes as federal agencies operate under a prolonged freeze in workforce expansion initiated by President Donald Trump's administration. Since January, the number of federal employees has dropped by more than 26,000, according to official estimates.
In response to reduced manpower, the Bureau of Labor Statistics has resorted to estimating prices in more cases than usual, using proxy data for goods and services where direct observations are unavailable.
See Also: <a href="https://www.benzinga.com/markets/market-summary/25/06/45809203/investors-pay-the-price-as-musk-trump-war-of-words-escalates-once-allies-now-foes-their-linked-stocks-crypto-and-funds-wipe-out-155-billion-in-a-single-day">Investors Pay The Price As Musk-Trump War Of Words Escalates: Once Allies, Now Foes, Their Linked Stocks, Crypto And Funds Wipe Out $155 Billion In A Single Day</a>
Why It Matters: The Consumer Price Index, which is derived from this research, is a key benchmark used to set interest rates, <a href="https://www.benzinga.com/personal-finance/25/05/45611852/social-security-set-to-make-history-by-crossing-2000-barrier-for-first-time-but-seniors-still-losing-ground-to-inflation">determine Social Security adjustments</a>, and guide household and business financial decisions. A less robust survey process, analysts say, could distort the true picture of inflation and mislead policymakers.
"This is the worst possible time to make staffing cuts to the CPI of all data sources," economist Ernie Tedeschi posted on social media, cautioning that both over- and underestimates of inflation carry serious consequences.
"The federal government hiring freeze and the drive to cut funding across federal agencies may be starting to impact the quality of economic data," warned Omair Sharif of Inflation Insights. He noted that statistical models now have to compensate for missing observations by extrapolating from similar goods.
&nbsp;"It's not a stretch to say that they affect the lives of everyday folks," Sharif added.
This news comes in the heels of a report from American consumers from the University of Michigan indicating that <a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high">American consumers remained deeply pessimistic in May 2025</a>, with confidence stuck at a three-year low and near-term inflation fears climbing to levels not seen since 1981. Another report from Yale University's Budget Lab shows that Trump's tariffs have led to a <a href="https://www.benzinga.com/news/politics/25/06/45787531/trumps-tariffs-hit-poorer-households-the-hardest-yales-budget-lab-finds-2-5-drop-in-disposable-income-for-bottom-decile">2.5 drop in disposable income</a> for the poorest households in the country.
Wall Street <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45353863/new-inflation-data-hits-tuesday-why-it-could-kill-fed-rate-cut-hopes">economists largely agree</a> that annual headline inflation will stay above 2.4%, keeping it above the Fed's 2% threshold for rate cuts—a trend many link to the tariff-driven spike in April.
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45809443/larry-summers-identifies-3-key-reasons-for-rising-us-debt-but-doesnt-think-trumps-big-beautiful-bill-is-the-medicine-the-country-needs">Larry Summers Identifies 3 Key Reasons For Rising US Debt, But Doesn&#8217;t Think Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Is The Medicine The Country Needs</a></li>
</ul>
Photo courtesy: Shutterstock

Inflation Data Collection Suffers Blow As Labor Department Suspends Price Tracking In Key Cities, Citing Worker Shortfalls

Shares of Rent the Runway, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) rose sharply in today's pre-market trading after the company posted better-than-<a href="https://www.benzinga.com/quote/RENT/earnings">expected quarterly results</a>.
Rent the Runway reported quarterly losses of 6.58 per share which beat the analyst consensus estimate of $8.35 per share. The company reported quarterly sales of $69.60 million which beat the analyst consensus estimate of $68.70 million.
Rent the Runway shares jumped 16.8% to $7.87 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Bluejay Diagnostics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) shares jumped 71.7% to $2.61 in pre-market trading after dipping 15% on Thursday.</li>
<li>Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) surged 37.9% to $4.33 in pre-market trading after jumping 50% on Thursday.</li>
<li>The Generation Essentials Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGE#NYSE">TGE</a>) jumped 31.4% to $13.21 in pre-market trading. The Generation Essentials Group recently announced it completed its busines comibination agreement through the acquisition of Black Spade.</li>
<li>Cambium Networks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) climbed 25% to $0.4020 in pre-market trading.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) surged 20.2% to $1.37 in pre-market trading after dipping 65% on Thursday. Helius Medical Technologies announced a $9.1 million public offering.</li>
<li>OFA Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) rose 18.5% to $3.28 in pre-market trading. OFA Group announced exercise and closing of underwriter&#8217;s full over-allotment option in connection with initial public offering.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) gained 15.2% to $95.47 in pre-market trading after gaining 168% on Thursday.</li>
<li>Distoken Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIST#NASDAQ">DIST</a>) rose 8.5% to $13.02 in pre-market trading.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 5% to $298.86 in pre-market trading after indications of a possible reconciliation between CEO Elon Musk and President Donald Trump. On Thursday, Tesla's market cap plummeted by a record $152 billion, marking the company's largest market cap loss in history. This decline was attributed to an intensified conflict between Musk and Trump over the latter's "Big Beautiful Bill."</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares dipped 34.7% to $20.00 in pre-market trading after falling 4% on Thursday.</li>
<li>lululemon athletica inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares fell 20.9% to $261.60 in pre-market trading after the company cut its FY25 GAAP EPS guidance below estimates.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) fell 19.2% to $75.10 in pre-market trading. DocuSign posted better-than-expected first-quarter results and announced a $1 billion increase to its share purchase program. Docusign said it sees second-quarter revenue in a range of $777 million to $781 million, versus the $774.75 million estimate. The company raised its fiscal 2026 revenue outlook to a range of $3.15 billion to $3.16 billion, versus the $3.14 billion estimate.</li>
<li>ZJK Industrial Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) fell 17.2% to $4.47 in pre-market trading after gaining 12% on Thursday.</li>
<li>Brag House Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>) fell 16.7% to $0.7500 in pre-market trading after the company announced it is working to file its delayed Q1 10-Q report.</li>
<li>Senmiao Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIHS#NASDAQ">AIHS</a>) shares fell 15.8% to $1.01 in pre-market trading after surging 28% on Thursday.</li>
<li>PepGen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) declined 15.5% to $1.20 in pre-market trading after falling 6% on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) fell 13.5% to $40.90 in today's pre-market trading following first-quarter results.</li>
<li>ServiceTitan, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) dipped 10.8% to $102.11 in pre-market trading after rge company posted quarterly results.</li>
<li>iPower Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares tumbled 10.2% to $0.4850 in pre-market trading after gaining 10% on Thursday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45790405/top-2-defensive-stocks-that-are-ticking-portfolio-bombs">Top 2 Defensive Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

AIHS

BJDX

CMBM

CRCL

DIST

EYEN

HSDT

LULU

OFAL

PEPG

RENT

TSLA

VERA

Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Ascendiant Capital analyst Edward Woo maintains Outlook Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>) with a Buy and lowers the price target from $24 to $21.

OTLK

Ascendiant Capital Maintains Buy on Outlook Therapeutics, Lowers Price Target to $21

Ascendiant Capital analyst Edward Woo maintains Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) with a Buy and raises the price target from $12 to $12.5.

PHUN

Ascendiant Capital Maintains Buy on Phunware, Raises Price Target to $12.5

Defense tech firm Anduril Industries has landed $2.5 billion in fresh capital, catapulting its valuation to $30.5 billion and marking a defining moment in its rapid rise within the national security sector.
What Happened: Executive Chairman Trae Stephens <a href="https://www.bloomberg.com/news/articles/2025-06-05/defense-startup-anduril-cllinches-funding-at-30-5-billion-valuation">announced</a> the funding milestone during an appearance on Bloomberg Television, revealing that Founders Fund, backed by billionaire Peter Thiel, led the round with a record $1 billion commitment, its largest investment to date. The firm's valuation has more than doubled since last year's $14 billion mark.
Anduril, headquartered in Southern California, designs next-generation defense technologies, from autonomous drones and battlefield software to advanced military wearables like AI-powered helmets and augmented reality goggles.
Its Columbus, Ohio, facility, Arsenal-1, is being outfitted to rapidly mass-produce such systems, including aerial and maritime drones.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/45786873/eminems-music-publisher-sues-meta-for-109-million-over-alleged-song-theft">Eminem&#8217;s Music Publisher Sues Meta For $109 Million Over Alleged Song Theft</a>
Why It Matters: The company's momentum comes amid <a href="https://www.benzinga.com/25/05/45611605/kim-jong-uns-regime-slams-trumps-golden-dome-missile-defense-project-as-nuclear-war-scenario">intensifying geopolitical tensions</a> and a growing reliance on unmanned systems in conflict zones. Following a high-profile drone strike by Ukraine on Russian forces, the <a href="https://www.benzinga.com/25/05/45548110/trumps-golden-dome-launches-new-era-for-defense-stocks-like-rtx-lockheed-martin-l3harris">accelerated role</a> of technology in modern combat is increasingly clear.
Co-founder Palmer Luckey said, "The US must accelerate its drone development in order to remain competitive with China." Meanwhile, the company's military contracts continue to expand. Its work on new infantry goggles for the U.S. Army could reach over $20 billion in value over the next decade.
Anduril also announced a partnership with Mark Zuckerberg&#8217;s Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) to co-develop <a href="https://www.benzinga.com/media/25/05/45687185/mark-zuckerbergs-meta-reunites-with-palmer-luckey-to-equip-us-soldiers-with-eagleeye-an-ai-powered-combat-headset-that-can-detect-drones">AI-enabled combat headsets</a>.
The company is positioning itself as a cornerstone of America's future defense strategy. "We did well under Trump and we did better under Biden," said Luckey. "I think we will do even better now."
Luckey has previously outlined his vision for America to become <a href="https://www.benzinga.com/markets/emerging-markets/25/05/45487876/america-must-shift-roles-from-world-police-to-world-gun-store-says-palmer-luckey">&#8220;the world gun store"</a> and countered U.N. Secretary-General António Guterres, who condemned fully autonomous lethal weapons as "politically unacceptable" and "morally repugnant," urging the adoption of an <a href="https://press.un.org/en/2025/sgsm22643.doc.htm">international ban by 2026</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45786646/meta-is-talking-exclusive-vr-content-with-disney-other-hollywood-studios-as-it-prepares-to-launch-its-apple-vision-pro-rival-report">Meta Is Talking Exclusive VR Content With Disney, Other Hollywood Studios As It Prepares To Launch Its Apple Vision Pro Rival: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Tada Images / Shutterstock.com

Markets

Anduril Raises $2.5 Billion At $30.5 Billion Valuation, Doubling In A Year As Defense Contracts Grow

Ascendiant Capital analyst Edward Woo maintains BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) with a Buy and raises the price target from $2.5 to $10.

BSGM

Ascendiant Capital Maintains Buy on BioSig Technologies, Raises Price Target to $10

Corporate America is experiencing a surge in layoffs as companies respond to economic pressures from President Donald Trump&#8217;s tariff policies and artificial intelligence adoption reshaping workforce needs.
What Happened: Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) revealed Thursday it will eliminate 7,000 jobs over two years, representing 15% of its non-manufacturing workforce, <a href="https://www.cnbc.com/2025/06/05/corporate-layoffs-companies-making-job-cuts.html">reported</a> CNBC. Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) cut 6,000 positions globally in May, followed by an additional<a href="https://www.benzinga.com/markets/tech/25/06/45738506/microsoft-fires-hundreds-more-workers-amid-ai-fueled-growth-calls-it-positioning-the-company-for-success"> 300 layoffs this week</a>, totaling approximately 3% of its workforce.
Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) reduced 1,500 positions across technology and e-commerce divisions, while The Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) cut several hundred employees worldwide from film and television units. Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) announced 3,500 job cuts in China, primarily affecting IT services.
Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) <a href="https://www.benzinga.com/markets/tech/25/06/45807611/amazon-cuts-jobs-in-kindle-goodreads-divisions-terms-it-a-difficult-decision">eliminated about 100 positions in its Kindle</a> and Goodreads divisions, adding to previous cuts across devices and services units. Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) reduced technology division staff, <a href="https://www.benzinga.com/25/05/45512822/nike-announces-layoffs-in-tech-division-shifts-focus-to-third-party-vendors">shifting work to third-party vendors. </a> See Also: <a href="https://www.benzinga.com/markets/equities/25/06/45808926/robinhood-says-overnight-trading-spiked-after-trumps-tariff-surprise-retail-came-to-the-rescue">Robinhood Says Overnight Trading Spiked After Trump&#8217;s Tariff Surprise: &#8216;Retail Came To The Rescue&#8217;</a> Why It Matters: Companies are implementing cost-cutting measures against the backdrop of President Trump&#8217;s tariff policies, with several firms citing artificial intelligence as a factor in workforce decisions. Klarna CEO Sebastian Siemiatkowski told CNBC in May that the fintech company reduced headcount by 40%, partly due to AI investments.
Microsoft's CFO Amy Hood recently told investors the company was focused on "building high-performing teams and increasing our agility by <a href="https://www.benzinga.com/markets/equities/25/05/45398101/microsoft-to-cut-6000-jobs-in-global-restructuring-joins-meta-and-amazon-in-trimming-workforce-amid-ai-driven-shift">reducing layers with fewer managers."</a> CEO Satya Nadella had earlier indicated that between 20% to 30% of the company's code was now being written using AI tools. Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45808672/nvidia-denies-report-of-re-entering-chinese-market-with-custom-ai-chip-despite-us-restrictions-we-are-still-evaluating">Nvidia Denies Report Of Re-Entering Chinese Market With Custom AI Chip, Despite US Restrictions: &#8216;We Are Still Evaluating&#8230;&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Tada Images / Shutterstock.coma

AMZN

MSFT

Walmart, Microsoft, Disney Slash Jobs As Trump Tariffs, AI Push Corporate America Into Layoff Mode

Press Releases

ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer

ArriVent BioPharma Reports Second Quarter 2024 Financial Results

ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

Comments

ArriVent BioPharma

Actualités

Dernières nouvelles pour ArriVent BioPharma (NASDAQ:AVBP) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL